arginine has been researched along with Osteosarcoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (19.05) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 6 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, HL; Li, ZH; Meng, ZY; Wang, YC; Xiao, Y; Zhao, Z | 1 |
| Chen, CC; Fu, SL; Lin, CH; Lin, WJ; Yang, JH | 1 |
| Bian, W; Guan, M; He, G; Li, J; Liu, J; Song, Y; Wang, Y; Xu, W; Zeng, X; Zhang, Y | 1 |
| Gong, Y; Wei, ZR | 1 |
| Hu, W; Jiang, J; Li, J; Liu, G; Liu, K; Liu, Q; Lou, Y; Yang, L; Yang, M; Zhang, Y; Zhao, P; Zhao, Z | 1 |
| Chai, Z; Chen, J; Du, C; Hu, Y; Jia, F; Liu, X; Lu, H; Ruan, L; Zhang, J; Zhou, M; Zhu, B | 1 |
| Horejsi, Z; Lidak, T; Macurek, L; von Morgen, P | 1 |
| Denessiouk, K; Denesyuk, A; Haag, S; Hansen, U; Heino, J; Holmdahl, R; Johnson, MS; Käpylä, J; Konttinen, Y; Peters, EC; Sipilä, K | 1 |
| Chang, R; Sun, L; Webster, TJ | 1 |
| Daniel, JA; Jensen, LJ; Larsen, SC; Lyon, D; Madsen, MV; Mullari, M; Mund, A; Nielsen, ML; Sylvestersen, KB | 1 |
| Cvetkovic, G; Evans, CH; Modiano, JF; O'Brien, TD; Rütgen, BC; Scott, MC; Tepic, S; Wells, JW | 1 |
| Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Canton, DA; Cooper, JA; Litchfield, DW; Niederstrasser, H; Olsten, ME | 1 |
| Berger, R; Bonvin, AM; Hamers, N; Hendriks-Stegeman, BI; Jeninga, EH; Kalkhoven, E; van Beekum, O; van Dijk, AD | 1 |
| Ghanta, VK; Hiramoto, RN; Kikuchi, Y; Parmley, RT; Takagi, M | 1 |
| Kato, K; Kikuchi, Y; Kizawa, I | 1 |
| Amado, JA; Fernández-Luna, JL; González-Macías, J; Olmos, JM; Riancho, JA; Salas, E; Zarrabeitia, MT | 1 |
| Ghebranious, N; Knoll, BJ; Lozano, G; Sell, S; Wu, H | 1 |
| McMaster, JH; Scranton, PE | 1 |
| Hirschfeld, S; Ho, PT; Pazdur, R; Smith, M | 1 |
| Sullivan, MP; Sutow, WW | 1 |
1 review(s) available for arginine and Osteosarcoma
| Article | Year |
|---|---|
Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives.
Topics: Antineoplastic Agents; Azacitidine; Child; Child, Preschool; Drug Approval; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neuroblastoma; Osteosarcoma; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; United States; United States Food and Drug Administration; Vindesine | 2003 |
20 other study(ies) available for arginine and Osteosarcoma
| Article | Year |
|---|---|
Mesoporous polydopamine-coated hydroxyapatite nano-composites for ROS-triggered nitric oxide-enhanced photothermal therapy of osteosarcoma.
Topics: Arginine; Bone Neoplasms; Catalysis; Cell Line, Tumor; Cell Survival; Durapatite; Humans; Indocyanine Green; Indoles; Infrared Rays; Nanocomposites; Nitric Oxide; Osteosarcoma; Phototherapy; Polymers; Porosity; Reactive Oxygen Species | 2021 |
Arginine Methylation of hnRNPK Inhibits the DDX3-hnRNPK Interaction to Play an Anti-Apoptosis Role in Osteosarcoma Cells.
Topics: Amino Acid Motifs; Apoptosis; Arginine; Cell Line, Tumor; DEAD-box RNA Helicases; DNA Damage; DNA-Binding Proteins; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Methylation; Models, Molecular; Mutation; Osteosarcoma; Protein Binding; Protein Conformation; Protein Interaction Domains and Motifs | 2021 |
Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3.
Topics: Arginine; Bone Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Osteosarcoma; RNA, Long Noncoding; Serine-Arginine Splicing Factors | 2022 |
MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1.
Topics: 3' Untranslated Regions; Animals; Arginine; Arginine Kinase; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Mice; MicroRNAs; Neoplastic Processes; Osteosarcoma; Protein Kinases; Protein Serine-Threonine Kinases; Serine | 2022 |
TIPE1 inhibits osteosarcoma tumorigenesis and progression by regulating PRMT1 mediated STAT3 arginine methylation.
Topics: Arginine; Bone Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Osteosarcoma; Protein-Arginine N-Methyltransferases; Repressor Proteins; STAT3 Transcription Factor | 2022 |
D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy.
Topics: Animals; Arginine; Cell Line, Tumor; Hypoxia-Inducible Factor 1, alpha Subunit; Metal-Organic Frameworks; Mice; Nanoparticles; Neoplasm Recurrence, Local; Osteosarcoma | 2021 |
Nuclear localisation of 53BP1 is regulated by phosphorylation of the nuclear localisation signal.
Topics: Active Transport, Cell Nucleus; Arginine; Bone Neoplasms; Cell Nucleus; HEK293 Cells; Humans; Karyopherins; Lysine; Nuclear Localization Signals; Osteosarcoma; Phosphorylation; Protein Binding; Tumor Cells, Cultured; Tumor Suppressor p53-Binding Protein 1 | 2018 |
Citrullination of collagen II affects integrin-mediated cell adhesion in a receptor-specific manner.
Topics: Amino Acid Motifs; Aminoacylation; Animals; Arginine; Bone Neoplasms; Cell Adhesion; Cell Line, Tumor; Cells, Cultured; Chickens; CHO Cells; Citrulline; Collagen Type II; Cricetinae; Cricetulus; Fibroblasts; Humans; Integrins; Mesenchymal Stem Cells; Osteoarthritis; Osteosarcoma; Peptide Fragments; Protein Binding; Protein Processing, Post-Translational; Rats; Recombinant Fusion Proteins; Synovial Membrane; Transfection | 2014 |
Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-RGD nanospheres.
Topics: Antineoplastic Agents; Arginine; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Microscopy, Electron, Transmission; Nanospheres; Oligopeptides; Osteoblasts; Osteosarcoma; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2015 |
Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells.
Topics: Arginine; Bone Neoplasms; HEK293 Cells; HeLa Cells; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Methylation; Nuclear Proteins; Osteosarcoma; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Proteome; Proteomics; Serine-Arginine Splicing Factors; Transcription Factors; Tumor Cells, Cultured | 2016 |
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
Topics: Adult Stem Cells; Animals; Antineoplastic Agents; Apoptosis; Arginase; Arginine; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Culture Media; Dogs; Leukemia; Lymphoma; Osteosarcoma | 2013 |
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Topics: Arginine; Ascorbic Acid; Bone Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinases; Neovascularization, Pathologic; Nutritional Physiological Phenomena; Osteosarcoma; Proline; Sarcoma, Ewing; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
The role of CKIP-1 in cell morphology depends on its interaction with actin-capping protein.
Topics: Actins; Amino Acid Sequence; Animals; Arginine; Carrier Proteins; Casein Kinase II; Cell Line, Tumor; Humans; Intracellular Signaling Peptides and Proteins; Molecular Sequence Data; Mutation; Osteosarcoma; Peptides; Phalloidine; Protein Binding; Sequence Homology, Amino Acid | 2006 |
Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.
Topics: Amino Acid Substitution; Arginine; Base Sequence; Bone Neoplasms; Cell Line, Tumor; Cysteine; DNA; DNA Mutational Analysis; DNA Probes; Genetic Carrier Screening; Humans; Lipodystrophy, Familial Partial; Models, Molecular; Osteosarcoma; PPAR gamma; Protein Conformation; Transcription, Genetic; Transfection | 2007 |
Inhibitory effect of L-homoarginine on murine osteosarcoma cell proliferation.
Topics: Alkaline Phosphatase; Animals; Arginine; Cell Division; Cells, Cultured; Depression, Chemical; Female; Homoarginine; Lysosomes; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Thymidine | 1982 |
[Inhibitory effect of L-homoarginine on murine osteosarcoma cell proliferation].
Topics: Alkaline Phosphatase; Amino Acids; Animals; Arginine; Cells, Cultured; Female; Homoarginine; Mice; Mice, Inbred C3H; Muramidase; Osteosarcoma; Sarcoma, Experimental; Stereoisomerism | 1982 |
Expression and functional role of nitric oxide synthase in osteoblast-like cells.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Base Sequence; Bone Neoplasms; Calcitriol; Calcium; Cell Division; Cytokines; DNA Primers; Dose-Response Relationship, Drug; Humans; Interleukin-6; Lipopolysaccharides; Molecular Sequence Data; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Osteoblasts; Osteosarcoma; Polymerase Chain Reaction; Rats; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure.
Topics: Aflatoxin B1; Amino Acid Sequence; Animals; Arginine; Base Sequence; Carcinoma, Hepatocellular; Codon; Creatine Kinase; Genes, p53; Hepatitis B; Humans; Liver Neoplasms; Mice; Molecular Sequence Data; Mutation; Neoplastic Stem Cells; Osteosarcoma; Promoter Regions, Genetic; Protein Conformation; Sequence Homology, Amino Acid; Serine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
Hormone therapy: a new approach to osteosarcoma.
Topics: Arginine; Carbohydrate Metabolism; Estradiol; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Osteosarcoma; Progesterone; Sex Factors; Thymidine; Tritium | 1974 |
Childhood cancer: the improving prognosis.
Topics: Asparaginase; Child; Cyclophosphamide; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Nitrogen Mustard Compounds; Osteosarcoma; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Rhabdomyosarcoma; Teniposide; Thioguanine; Vincristine; Wilms Tumor | 1976 |